BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 26, 2002
View Archived Issues
Cephalon Filing Supplemental NDA For New Sleep Disorders
As generic competition looms for its narcolepsy tablet Provigil, Cephalon Inc. said it has filed a supplemental new drug application seeking a broadened label that would include other sleep and wakefulness disorders. (BioWorld Today)
Read More
Merck Returns To Isis Rights To Preclinical Antisense Drug
Read More
Mice Teach Geneticists Strategies For Exploiting Circadian Rhythms In Treating Modern Sleep Disorder
Read More
Beckman Coulter Buying SNPs Genotyping Assets From Orchid
Read More
Holiday Notice
BioWorld's offices were closed Tuesday and Wednesday for the holiday season, and no issues were published those days.
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
U.S. Patent Disclosures
Read More